(Q26866336)

Giuffrida FM

2

1 reference

Crispim F

3

1 reference

Saddi-Rosa P

4

1 reference

Reis AF

5

1 reference

language of work or name

1 reference

October 2011

1 reference

Arquivos Brasileiros de Endocrinologia e Metabologia

published in

1 reference

volume

55

1 reference

issue

7

1 reference

page(s)

446-54

1 reference

Adiponectin gene and cardiovascular risk in type 2 diabetic patients: a review of evidences.

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302011000700003

Why does diabetes increase atherosclerosis? I don't know!

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302011000700003

Adiponectin: A novel adipokine linking adipocytes and vascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302011000700003

Adiponectin--journey from an adipocyte secretory protein to biomarker of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302011000700003

Visfatin, glucose metabolism and vascular disease: a review of evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302011000700003

Genetics of macrovascular complications in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302011000700003

Genetic effects of adiponectin on blood lipids and blood pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302011000700003

Adiponectin gene ADIPOQ SNP associations with serum adiponectin in two female populations and effects of SNPs on promoter activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302011000700003

Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302011000700003

Insulin resistance influences the association of adiponectin levels with diabetes incidence in two population-based cohorts: the Cooperative Health Research in the Region of Augsburg (KORA) S4/F4 study and the Framingham Offspring Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302011000700003

Plasma adiponectin levels and risk of myocardial infarction in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302011000700003

Adiponectin and mortality in patients undergoing coronary angiography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302011000700003

Plasma adiponectin for prediction of cardiovascular events and mortality in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302011000700003

Low plasma adiponectin concentration is associated with myocardial infarction in young individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302011000700003

Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302011000700003

Association of adiponectin with coronary heart disease and mortality: the Rancho Bernardo study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302011000700003

Adiponectin and future coronary heart disease events among men with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302011000700003

Adiponectin and risk of coronary heart disease in older men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302011000700003

Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302011000700003

Adipocytokines and the risk of coronary heart disease in healthy middle aged men: the PRIME Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302011000700003

Hypoadiponectinemia--cause or consequence of human "insulin resistance"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302011000700003

Serum high-molecular-weight adiponectin as a marker for the evaluation and care of subjects with metabolic syndrome and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302011000700003

Comparison of serum high-molecular weight (HMW) adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302011000700003

Atherogenic dyslipidaemia but not total- and high-molecular weight adiponectin are associated with the prognostic outcome in patients with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302011000700003

High molecular weight adiponectin as a predictor of long-term clinical outcome in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302011000700003

Adiponectin, diabetes, and coronary heart disease in older persons: unraveling the paradox

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302011000700003

High-molecular-weight adiponectin does not predict cardiovascular events in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302011000700003

Genetic influences of adiponectin on insulin resistance, type 2 diabetes, and cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302011000700003

Genetic architecture of plasma adiponectin overlaps with the genetics of metabolic syndrome-related traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302011000700003

A genome-wide association study reveals variants in ARL15 that influence adiponectin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302011000700003

Clear detection of ADIPOQ locus as the major gene for plasma adiponectin: results of genome-wide association analyses including 4659 European individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302011000700003

ADIPOQ, ADIPOR1, and ADIPOR2 polymorphisms in relation to serum adiponectin levels and BMI in black and white women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302011000700003

Circulating high molecular weight adiponectin isoform is heritable and shares a common genetic background with insulin resistance in nondiabetic White Caucasians from Italy: evidence from a family-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302011000700003

Association of the +45T>G and +276G>T polymorphisms in the adiponectin gene with insulin resistance in nondiabetic Greek women

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302011000700003

The adiponectin gene SNP+45 is associated with coronary artery disease in Type 2 (non-insulin-dependent) diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302011000700003

Adiponectin I164T mutation is associated with the metabolic syndrome and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302011000700003

The +276 polymorphism of the APM1 gene, plasma adiponectin concentration, and cardiovascular risk in diabetic men

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302011000700003

Adiponectin genetic variability, plasma adiponectin, and cardiovascular risk in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302011000700003

Interaction of ADIPOQ genetic polymorphism with blood pressure and plasma cholesterol level on the risk of coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302011000700003

Associations of SNPs in ADIPOQ and subclinical cardiovascular disease in the multi-ethnic study of atherosclerosis (MESA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302011000700003

Common variants in the adiponectin gene (ADIPOQ) associated with plasma adiponectin levels, type 2 diabetes, and diabetes-related quantitative traits: the Framingham Offspring Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302011000700003

Circulating Adiponectin Levels and Mortality in Elderly Men With and Without Cardiovascular Disease and Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302011000700003

Adiponectin and Coronary Heart Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302011000700003

Single Nucleotide Polymorphisms at the Adiponectin Locus and Risk of Coronary Heart Disease in Men and Women*

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302011000700003

Common Adiponectin Gene Variants Show Different Effects on Risk of Cardiovascular Disease and Type 2 Diabetes in European Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302011000700003

Prognostic Value of Adiponectin for Cardiovascular Disease and Mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302011000700003

10.1590/S0004-27302011000700003

21 January 2018

Identifiers

DOI

0 references

PubMed publication ID

22147092

1 reference